Podovirus

Why don’t we have phage therapy yet?

Jessica Sacher, Joe Campbell and Bekah Dedrick ask the people doing the work.

Play latest episodeCan We Optimize Phage Therapy Dosing?

Why this podcast?

Phages (bacteriophages) are viruses that kill bacteria with sniper-like precision. They can be incredibly useful for treating life-threatening infections ('phage therapy'), and can help us reduce our dependence on antibiotics. They've been known for 100 years... so WHY do we still not see them on the shelves?

Jessica Sacher, PhD (Staff Scientist at Stanford and cofounder of Phage Directory) and Joseph Campbell, PhD (former NIAID program officer) talk to phage therapy practitioners, researchers and entrepreneurs to understand one question: why don't we have phage therapy yet?

Meet your hosts

Host / Producer

Jessica “Jess” Sacher

Phage Directory cofounder and phage scientist. Jess produces Podovirus and brings questions from the people working to make phage therapy real.

Meet Jess ↗

Co-host

Joseph “Joe” Campbell

Former NIAID program officer. Joe brings a view of phage research, funding and the long road from promising science to patient care.

Joe on LinkedIn ↗

Co-host

Bekah Dedrick

Phage researcher whose work includes mycobacterial infections and cystic fibrosis.

Meet Bekah ↗

Every conversation

23 episodes

  1. 36 min

    Can We Optimize Phage Therapy Dosing?

    A podcast interview with Gauri Rao, Associate Professor, Director of Center for Quantitative Disease & Drug Modeling at the University of Southern California.

    Listen